WELCOME! - Physician Town Hall - Saskatchewan Health Authority
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Town Hall Reminders • This event is being recorded and will be available to view on the Physician Town Hall webpage • If you have any questions or comments during the event, please enter them in the Q&A section • Watch for this icon during the event and respond to our live polls
Truth and Reconciliation We would like to acknowledge that we are gathering on Treaty 2, 4, 5, 6, 8 and 10 territory and the Homeland of the Métis. Recognizing this history is important to our future and our efforts to close the gap in health outcomes between Indigenous and non-Indigenous peoples. I pay my respects to the traditional caretakers of this land.
Agenda COVID-19 Surveillance and Epidemiological Trends Dr. Julie Kryzanowski COVID-19 Modelling Update Dr. Jenny Basran COVID-19 Offensive Strategy Dr. Johnmark Opondo • COVID Vaccine Update Dr. Kevin Wasko and Dr. Jessica Minion COVID-19 Defensive Strategy Dr. John Froh and John Ash • PSE Update Dr. John Froh • PPE Update Dr. Michael Kelly Physician Wellness Dr. Andriyka Papish Your Turn! Poll on Topics/Q&A Vote in our live poll and submit questions!
COVID-19 Surveillance and Epidemiological Trends Dr. Julie Kryzanowski Senior Medical Health Officer
Epidemic curve, SK-COVID-19 pandemic, by zone, Feb 1, 2020 – Jan 13, 2021 (n = 19,017) 400 20000 Central East Central West 18000 350 Far North East Far North West 16000 300 North Central North East 14000 250 12000 Number of Cases North West Regina Cumulative 200 10000 Saskatoon South Central 8000 150 South East South West 6000 100 Unknown Region Far North Central 4000 50 2000 0 0 2/21/2020 3/21/2020 4/21/2020 5/21/2020 6/21/2020 7/21/2020 8/21/2020 9/21/2020 10/21/2020 11/21/2020 12/21/2020 Source: Panorama, IOM
New COVID-19 cases per 100,000 last 7-days, by province, March 2020 - Jan 12 2021 Source: Public Health Agency of Canada https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html
COVID-19 cases, rate per 100,000, last 7- days, by province/territory, Jan 13 2021 SK now has the second highest case rate in the country after Quebec Source: Public Health Agency of Canada https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html
Number of Cases 0.0 100.0 50.0 150.0 200.0 250.0 300.0 12/1/2020 12/2/2020 Source: Interactive epi file 12/3/2020 12/4/2020 12/5/2020 12/6/2020 12/7/2020 12/8/2020 12/9/2020 12/10/2020 12/11/2020 12/12/2020 12/13/2020 Cases 12/14/2020 12/15/2020 12/16/2020 12/17/2020 12/18/2020 12/19/2020 12/20/2020 12/21/2020 12/22/2020 12/23/2020 12/24/2020 12/25/2020 12/26/2020 12/27/2020 12/28/2020 12/29/2020 12/30/2020 12/31/2020 Test Positivity 1/1/2021 1/2/2021 1/3/2021 1/4/2021 1/5/2021 1/6/2021 positivity, SK, Dec 1, 2020 - Jan 10, 2021 1/7/2021 1/8/2021 1/9/2021 1/10/2021 0.0 2.0 4.0 6.0 8.0 10.0 12.0 Test Positivity (%) 7-day rolling average, COVID-19 cases and test
COVID-19 deaths, SK-COVID-19 pandemic, Mar 31, 2020 – Jan 13, 2021 (N = 206) 140 120 117 100 The majority of Number of deaths 80 deaths 60 (n = 159; 77%) 40 42 have occurred 22 in the last 6 20 2 4 5 2 5 6 0 1 weeks 0 March April May June July August September October November December January, 2021 Source: Saskatchewan Ministry of Health, Dashboard (https://dashboard.saskatchewan.ca/health-wellness)
Monitoring Indicator summary, Dec 28, 2020 to Jan 10, 2021 • Epidemic DT and R(t) indicating potential PLATEAU in exponential growth • Testing rate increasing • Hospitalization decreased • All indicators demonstrating concerning trend Source: Saskatchewan Ministry of Health, Weekly Integrated Epi Report
Assessed Risk of Epidemic Transmission, by Zone, Dec 30, 2020 – Jan 12, 2021 Previous week Current week Colour Threshold level for * Epidemic Spread “The New Normal” COVID transmission is controlled, but there is a risk of community transmission. High risk that COVID transmission is not controlled. High likelihood that COVID transmission is not controlled. Week Dec 30 – Jan 5 Week Jan 6 – 12 Source: COVID-19 Coordinating Committee and SK-MHO Committee
COVID-19 Modelling Update Dr. Jenny Basran Senior Medical Health Officer
Impact of Public Health Measures on Lab Confirmed Cases Modelling chart includes holiday season trend. Rate of growth depends on degree of update of public health measures. CEPHIL Agent Based Model study results with 95% quantile SK COVID-19 Modelling Initiative – Joint partnership between U of S CEPHIL lab, SHA and the MOH
Impact of Public Health Measure on Hospital Census Modelling chart includes holiday season trend. Hospital census changes lag behind changes to cases by 1-2 weeks. Rate of growth slower with higher uptake of public health measures. CEPHIL Agent Based Model study results with 95% quantile SK COVID-19 Modelling Initiative – Joint partnership between U of S CEPHIL lab, SHA and the MOH
Impact of Public Health Measures on ICU Census Modelling chart includes holiday season trend. ICU census changes lag behind cases by 1-2 weeks and hospital census by another week. Rate of growth depends on degree of update of public health measures. CEPHIL Agent Based Model study results with 95% quantile SK COVID-19 Modelling Initiative – Joint partnership between U of S CEPHIL lab, SHA and the MOH
Offensive Strategy Update Dr. Johnmark Opondo Medical Health Officer – Offensive Strategy COVID-19 Health System Readiness Update
Offensive Strategy Key goal: prevent, contain and mitigate viral spread and promote population health Key work of Public Health: 1. Emergency preparedness and response, including cross-sector business and service continuity 2. Epidemiology and surveillance: understand patterns of transmission to adjust response measures 3. Case, contact and outbreak investigation and management • Population-based measure that aims to interrupt networks of transmission and control epidemic • Notification Isolation/Quarantine Investigation Reporting Monitoring Evaluation • Assisted Self-Isolation Sites (ASIS), ASIS Medical and Secure isolation sites (SIS) • Risk assessment: case communicability period, acquisition, exposure setting(s), contacts 4. Testing strategy: symptomatic, active case finding (investigations), public health surveillance 5. Enforcement: Public Health Orders, Public Health inspection, compliance/education 6. Risk communication: public awareness, behavior change, population health promotion 7. Covid-19 Immunization planning and delivery
New Canadian Border Measures As of January 7th, Canada is implementing pre-departure testing for any flight coming into Canada. Anyone 5 years+ is required to have a negative molecular test within 72hr (some cases extended to 96hr) prior to boarding. Passengers are required to bring the documentation to the airline (if don’t have, then prohibited from boarding) and need to be ready to produce to government/public health officials if asked during quarantine). A 14-day quarantine period is still required. Federal government is procuring security to do quarantine site visits. Desire to strengthen enforcement. Some exemptions exist (e.g. for crew members, emergency providers, essential service providers, Canadian officials on foreign assignment, etc).
Amendments to Disease Control Regulations re: COVID Expand the scope of who can do contact tracing 1. All persons who are assigned contact tracing or related duties by the SHA; and 2. All persons who are assigned contact tracing or related duties by an entity contracted by the SHA to provide an external workforce in relation to contact tracing. With respect to section 8.2(2) and the requirement that designated persons have the qualifications, educational background or experience that the Chief Medical Officer has determined is appropriate, please be advised that the classes of persons outlined above have some or all of the following experience/qualifications: · They are employees or contractors of the SHA; · They are employees of the Saskatchewan Public Service Commission; · They are employees of Statistics Canada or related agencies; or · They are learners in Nursing, Medicine, or other medical fields
Outbreak Mx. Response Current Strategies Outbreak Prevention Outbreak Response Continuing Care Resource Team HR Affiliate Workforce Plan LTC Pathway POCT Daily contact and support with LTC Home Continuing Care Director on call 7 days a week to support Homes in outbreak Outbreak simulations Equipment and PPE Monitoring Temporary Closure of 4 bed rooms Daily Outbreak Calls Daily Staffing Huddles IPC Consultant Site Visits
COVID-19 Vaccine Update Dr. Kevin Wasko Co-Chair COVID-19 Immunization Clinical Expert Advisory Committee
Updated HCW & Vulnerable Populations Framework NACI guidelines Priority for early COVID-19 vaccination will be given to the following populations: • residents and staff of shared living settings who provide care for seniors • adults 70 years of age and older, with order of priority: • beginning with adults 80 years of age and older • decreasing the age limit by 5-year increments to age 70 years as supply becomes available • adults in Indigenous communities Definition of Vulnerable Populations: those at high risk for severe illness and death, those most likely to transmit to those at high-risk and those in living or working conditions with elevated risk for infection or disproportionate consequences
Phase 1: HCW/Vulnerable Populations Health Care Worker Vulnerable Populations • HCW of congregate living settings for LTC/PCH residents and staff older adults (long term care and personal care homes) Residents of First Nations Communities over • Adult ICU the age of 40 • Emergency department Age > 80 and Indigenous adults age >60 • Respiratory Therapy • Covid-19 designated wards Age > 70 and Indigenous Adults age > 50 • Code blue and trauma teams • Covid-19 assessment and testing centers • EMS, road and air transport teams Planned or post solid organ and bone • All HCW over age 70 marrow/stem cell transplant Patients on Dialysis
Phase 2a: HCW Vulnerable Populations Health Care Worker Vulnerable Populations • HCW of congregate living situations for Residents and staff of shared living situations [language vulnerable adult populations from NACI guidelines] for seniors not included above • seniors’ assisted living • Anesthesia / Operating Rooms • All other critical care Residents and staff of other shared living settings2 • homeless shelters and other emergency shelters • Hemodialysis • group homes • Vaccination team • mental health residential care • non-federally regulated correctional institutions • Radiology technicians • Congregate Living Arrangements • ECG/echo Medically vulnerable populations • Phlebotomy/Lab Workers handling COVID • Malignant Hematology patients on active treatment specimens • Solid Tumor Oncology patients on active treatment • Home care (direct care providers)
Phase 2b and c: HCW Vulnerable Populations Health Care Worker Vulnerable Populations Phase 2b: All other direct clinical care including: Phase 2b • Physicians • We recommend further engagement with Indigenous • RN and LPN partners for additional sequencing of Indigenous • Therapists (physical, occupational, speech populations in the province. • Ward clerks • We recommend further engagement with community • Outpatient clinic staff partners for additional sequencing of socially vulnerable • Mental health providers populations in the province. • Patient registration • Housekeeping/environmental services Phase 2c • Dietary staff • Outreach as general population roll out • Security • Social workers & case managers • CPAs • Chaplain staff • Dentists and dental clinics (direct care providers) • Pharmacists and pharmacies (direct care providers) • Community based health workers on First Nations Communities • Traditional/cultural workers Phase 2c: HCWs not included above
John & Shirley
Phase One - Priority Populations Category Long term care/personal care home residents and staff Prioritized health care workers Ages 80+ years Ages 70-79 Remote/North 50+ Currently planned Federal allocations for Phase One leave us approximately 50% short of fully immunizing the high priority populations approved by the COVID-19 Immunization Oversight Committee and as recommended by clinical and ethical experts
Faster – Key Strategies Speed matters. Every day counts to save lives and reduce the overall impact of COVID-19. Hub Model: Establish Pfizer/Moderna distribution hubs in approx. 20 locations All hands on deck: Deliver through all appropriate health care providers and available external resources Continue supporting & strengthening mobile immunizations teams Test new delivery methods locally for priority populations and determine ability to scale up or utilize in other locations Forecast vaccine distribution further in to the future to enable teams to better prepare for rapid distribution • Stable, predictable and large volume allocations enable more rapid delivery Ensuring all areas of the province are in a state of readiness for rapid and safe delivery of the vaccine as quickly as possible once they receive it
Smarter Learning matters: Continuous improvement is already resulting in more rapid delivery Leveraging our experience from the influenza vaccine, but also recognizing where it’s different and adapt accordingly • Key differences: limited, variable and unpredictable allocations, the need to sequence priority populations, multiple vaccines and more complex transportation/distribution Identifying improvements from initial pilot/early phases • e.g. transportation improvements are already increasing pace of delivery Empowering teams to identify creative/innovative delivery methods • Power of a single health authority is that good ideas can be more easily scaled/replicated in different areas of the province Learning from our partners: Planning and vaccine delivery will be coordinated with stakeholders (First Nations/Metis Partners, CBOs, etc)
Safe Safety matters: High uptake requires strong communications to ensure the public knows the vaccine is safe The COVID-19 Vaccine is: • Safe – Health Canada approved • Effective – 90%+ reduction in infection • Simple – like getting a flu shot The World Health Organization: • Estimates that vaccines save 2-3 million lives in a normal year • Lists vaccine hesitancy as one of the top 10 global health risks
Key Challenges • Delivering to high risk populations up North in early phases was the right decision, but did slow initial rollout • Pfizer is more logistically challenging to distribute to rural/remote locations • Time-intensive consent process, high volume booking processes • Limited, variable and unpredictable allocations • Adverse winter weather may cause transportation challenges at times, especially in rural and remote settings • Resources strained given the need for continued pandemic response • Significant challenges given high COVID cases, hospitalizations, etc.
Key Next Steps & Key Messages Key Next Steps: • Continue to build out prioritization of groups for phase two • Continue to prepare for widespread immunization in phase two • Ensure teams are ready to deliver vaccine as soon as possible on arrival to enhance speed of delivery Key Messages: • Safety of our patients, residents and health care workers is our #1 priority • Speed matters. That is why we need to continually get faster and smarter. • Stable, predictable and large volume allocations make rapid delivery easier • Our health care system is at its most fragile point yet. The public needs to remain vigilant.
COVID Vaccine Update Week of January 11, 2021
SHA COVID Vaccine Administration Data Area Distribution Administered Remaining % Administered *Extra Doses Regina 3900 4001 0 103% In Vials Saskatoon 11700 3537 8378 30% North Central 3900 1258 2642 32% Far Northwest 1450 956 494 66% Far Northeast 1370 1261 109 92% Northeast 1370 715 655 52% Athabasca Health Authority 710 257 453 36% Provincial Totals Saskatchewan 24400 11985 12630 49%
New SK Vaccine Administration Targets Date # of Doses Administered in SK/day January 13-14, 2021 1000/day January 15-19, 2021 1500/day January 20-31, 2021 2000/day February 1, 2021 2500/day
Emerging SARS-CoV-2 Variants Dr. Jessica Minion Provincial Clinical Lead Public Health – Laboratory Medicine
New Viral Variants • Viruses constantly change through mutation, and new variants of a virus are expected to occur over time. • Sometimes new variants emerge and disappear. • Other times, new variants emerge and persist. • Multiple variants of the virus that causes COVID-19 have been documented globally during this pandemic • SARS-CoV-2 has not mutated very quickly in general • Accumulation of mutations averages 1-2/month • i.e. most genomes sequenced today have ~20-25 mutations compared to isolates from China in January 2020 https://www.nature.com/articles/s41564-020-0770-5
UK Variant • In the United Kingdom (UK), a new variant has emerged • Known as 20B/501Y.V1, VOC 202012/01, or B.1.1.7 lineage • First detected in September 2020 • Unusually large number of mutations (17 from nearest branch) • Evidence that it appears to spread more easily: epidemiologic & in vitro studies • No indication that it causes more severe illness or increased risk of death • Unusually large number of mutations • 17 from nearest branch, 8 in the gene that encodes the spike protein on surface of virus • N501Y = at position 501, amino acid asparagine (N) has been replaced with tyrosine (Y): increases how tightly it binds onto ACE-2 receptor, its entry point into human cells • 69-70del = deletion of 2 amino acids in the spike protein: has been found in viruses that elude immune response in immunocompromised patients
UK Variant UK variant has been detected in 35 countries 23 cases have been detected in Canada (ON=14, AB=4, BC=4, QC=1); all have been connected to international travel (3 investigations still pending) http://cov-lineages.org/global_report_B.1.1.7.html Accessed January 14, 2021
South African Variant • In South Africa, another variant has emerged independently of the variant detected in the UK. • Known as 20C/501Y.V2 or B.1.351 lineage • First detected in October 2020 • Shares some mutations with the B.1.1.7 lineage, including multiple mutations in the spike protein such as N501Y. • Evidence that it appears to spread more easily • No indication that it causes more severe illness or increased risk of death • As of January 13, 2021, one case has been identified in Canada (=AB) in a recent traveler.
South African Variant N=12 countries https://cov-lineages.org/global_report_B.1.351.html accessed January 14, 2021
Ongoing Surveillance • Other variants are constantly being recognized and investigated • Currently no others have been classified as a “VOC” or Variant of Concern • Looking for both epidemiologic associations with increased transmission and specific mutations hypothesized to cause changes to transmissibility or antigenicity • Epidemiologic monitoring of viral sequences varies greatly across different countries, with UK being the gold standard globally • In Canada, national surveillance program: CanCoGen • Has sequenced over 25,000 viral genomes so far • SK Selection strategy • 50% randomly selected cases to determine background transmission • 50% directed: all travel-related, potential reinfections, vaccine escape, unusual severity, outbreaks
Potential Consequences of Emerging Variants • Ability to spread more quickly in people. • Epidemiologic evidence, in vitro evidence • Ability to cause either milder or more severe disease in people. • There is no evidence that these recently identified SARS-CoV-2 variants cause more severe disease than earlier ones. • Ability to evade detection by specific diagnostic tests. • Most polymerase chain reaction (PCR) tests have multiple targets to detect the virus, such that even if a mutation impacts one of the targets, the other PCR targets will still work. • Decreased susceptibility to therapeutic agents such as monoclonal antibodies. • Ability to evade natural or vaccine-induced immunity. • Both vaccination against and natural infection with SARS-CoV-2 produce a “polyclonal” response that targets several parts of the spike protein. The virus would likely need to accumulate multiple mutations in the spike protein to evade immunity induced by vaccines or by natural infection.
References • Genetic Variants of SARS-CoV-2—What Do They Mean? • https://jamanetwork.com/journals/jama/fullarticle/2775006 • The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem • https://pubmed.ncbi.nlm.nih.gov/33377359/ • UK Government: New SARS-CoV-2 variant • https://www.gov.uk/government/collections/new-sars-cov-2-variant • Covid-19: What have we learnt about the new variant in the UK? • https://www.bmj.com/content/371/bmj.m4944 • Could new COVID variants undermine vaccines? Labs scramble to find out • https://www.nature.com/articles/d41586-021-00031-0 • WHO: Episode #20 - COVID-19 - Variants & Vaccines • https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/science-in-5/episode-20- --covid-19---variants-vaccines
Defensive Strategy Dr. John Froh Deputy Chief Medical Officer – Pandemic John Ash Executive Director of Acute Care Regina COVID-19 Health System Readiness Update
Provincial Acute Capacity Report
COVID-19 Hospital Census
Acute Care Surge – Provincial Strategies Target Condition: Proactively prepare for anticipated acute care surge. Multiple strategies underway at local and provincial level. Some of the key provincial strategies: • Weekly operational COVID requirement of all IHICCs issued this morning with updated acute care capacity targets based upon modeling data. • Implementation of rapid point of care testing in acute care to support screening, placement and outbreak management strategies. • Acute Care oxygen system monitoring and upgrades • Provincial load balancing of inpatients across acute care facilities • Needs assessment and planning to enhance critical care transport capacity • Establishment of local multidisciplinary outbreak management teams
Physician Skills Enhancement Update
Physician Skill Enhancement (PSE) Program Update Hospital remains most urgent need! Emergency Pandemic Skills Program % to Target (Target = 95 Trained Physicians) Sign up through Pandemic Skills Inventory! ICU Pandemic Skills Program % to Target (Target = 80 Trained Physicians) Hospital Pandemic Skills Program % to Target (Target = 160 Trained Physicians) Red -
Physician Deployment Update Week Location(s) Physician(s) Actively Deployed December 27, 2020 – January Weyburn Yes 2, 2021 January 3 – 9, 2021 Weyburn Yes January 10 – 16, 2021 Weyburn Yes
Personal Protective Equipment (PPE) Update Dr. Michael Kelly EOC Safety Officer
PPE Update • Current PPE supply is secure • Now receiving 100K/month - Kimberly Clark N95s on top of 3M allocation • Vaccination status does not impact PPE requirements and isolation requirements after exposure
Safety Bulletins - PPE guidelines can be found at Saskatchewan.ca/COVID19- providers - In the spring the SHA released a weekly PPE Bulletin every Friday that provided information to staff and physicians on PPE recommendations - The PPE bulletin is now the Safety Bulletin and includes a wider variety of topics all under the Safety umbrella as it relates to COVID-19.
Droplet Contact Plus Precautions for COVID-19
Physician Wellness Dr. Andriyka Papish Consulting Psychiatrist, Regina, SK Co-Lead, Psychiatry Response Team for COVID-Care Providers Physician Health Program, SMA
I see my colleagues struggling… What can I do?
How leaders can support team resilience in a pandemic CMA Physician Wellness Hub: 4 key points 1. Educate yourself about signs of stress & trauma 2. Carve out regular time for reflective discussions with your team • Strive for the “Hobfoll five”: 5 essential elements of psychosocial support i. a sense of safety ii. promote calming iii. remind team members of their sense of efficacy individually and as a team iv. Connectedness v. talk about hope and sense of purpose • https://www.cma.ca/physician-wellness-hub/resources/resilience/how-leaders-can-support-team-resilience • https://www.mentalhealthcommission.ca/English/online-training-psychological-health-and-safety • https://haruv.org.il/wp-content/uploads/2020/04/Hobfoll-et-al-2009.pdf
How leaders can support team resilience in a pandemic CMA Physician Wellness Hub: 4 key points 3. Model the behaviours you want to see • “Real leaders are forged in crisis” • 10 steps to help ensure psychological wellbeing of health care staff during COVID 4. Find champions that also model these behaviors • https://hbr.org/2020/04/real-leaders-are-forged-in-crisis • https://www.bps.org.uk/sites/www.bps.org.uk/files/News/News%20-%20Files/Psychological%20needs%20of%20healthcare%20staff.pdf • https://healthcare.utah.edu/publicaffairs/news/2021/01/covid-mental-health.php
Your Physician Health & Wellness Supports Reflect on one thing that Town Hall Physician Wellness Webex Series Physician Wellness and Support webpage brought you hope and a Health Care Worker Mental Health Support Hotline: sense of purpose in 1-833-233-3314 (8am – 4:30pm, Monday-Friday) your work today. Saskatchewan Medical Association Physician Health Program Saskatoon, NE, NW: Brenda Senger Thank you for attending 306-657-4553 to your own self care - Regina, SE/SW: Jessica Richardson this improves patient 306- 359-2750 care.
Partners Thank you to our partners!
Q&A Please respond to Please enter your question in the Q&A section the live poll! OR Raise your hand and we will unmute you so you can comment or ask your question live
Next Town Hall Regular town hall meetings will be every Thursday evening from 18:00-19:30 Thank you for attending!
You can also read